Table of Contents
Volume 2 | Issue 4
Publication Date: February 2003- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
202 |
Clinical Colorectal Cancer: The Epidermal Growth Factor Receptor Signaling Pathway as a Chemotherapeutic Target Edward Chu |
|
Researches in Brief | ||
205-209 |
The Combination of Capecitabine and Oxaliplatin in Metastatic Colorectal Cancer Kavita Maung, Heather DeGrendele, Edward Chu, Vinay K. Jain |
|
210-212 |
Advances in the Use of Fecal DNA Screening for the Detection of Colorectal Cancer Heather DeGrendele, Edward Chu, Vinay K. Jain |
|
Comprehensive Reviews | ||
213-222 |
Adjuvant Radiation Therapy of Patients with Rectal Cancer John Bechtel, Joel Tepper |
|
223-230 |
Predictive Markers for Colorectal Cancer: Current Status and Future Prospects Daniel B. Longley, Ultan McDermott, Patrick G. Johnston |
|
Original Contribution | ||
231-234 |
Analysis of Clinical Prognostic Factors for Survival and Time to Progression in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy Ana L. Yuste, Jorge Aparicio, Angel Segura, Pedro López-Tendero, Regina Gironés, José A. Pérez-Fidalgo, Roberto Díaz, Verónica Calderero |
|
Commentary | ||
235-238 |
Clinical and Molecular Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy Robin L. Jones, David Cunningham |
|
Original Contribution | ||
239-244 |
Neural Networks in the Prediction of Survival in Patients with Colorectal Cancer Simon Grumett, Pete Snow, David Kerr |
|
Commentary | ||
245 |
Predicting Survival with Artificial Neural Networks Romano Danesi, Antonello Di Paolo |
|
Translational Medicine | ||
246-251 |
Epidermal Growth Factor Receptor as a Therapeutic Target in Colorectal Cancer Roger B. Cohen |
|
Commentary | ||
252 |
Epidermal Growth Factor Receptor and Other Molecular Targets in the Treatment of Cancer Chris H. Takimoto |
|
Current Trial | ||
253-256 |
Phase I/IIA Randomized Study of PHY906, a Novel Herbal Agent, as a Modulator of Chemotherapy in Patients with Advanced Colorectal Cancer Michael P. Farrell, Shivaani Kummar |
|